In our previous studies [6, 7], we had demonstrated that Re improved CHD by reducing oxidative stress and TGF-β levels, which are both important factors of the progress of NAFLD [14, 28, 29]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatotic liver disease.